Skip to content

PALI PALISADE BIO INC

Follow

COMMON STOCK (common), issuer CIK 1357459

Filings received so far for Q3 2026: 2 13F filers report a position in PALI shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Jones Mitchell Lawrenceofficer (See Remarks)2026-10-06-1,031,102 F$1.49Form 4
Jones Mitchell Lawrenceofficer (See Remarks)2026-10-06+2,620,850 MForm 4
Finley John Daviddirector, officer (CEO CFO)2026-10-06-1,411,982 F$1.49Form 4
Finley John Daviddirector, officer (CEO CFO)2026-10-06+3,227,384 MForm 4

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Farther Finance Advisors, LLC4,185$5.65K<0.01%new13F-HRTimeline
GAMMA Investing LLC559$755<0.01%new13F-HRTimeline

Events

  • Jones Mitchell Lawrence acquired 1,589,748 PALI shares on 2026-10-06, Form 4 filed 2026-10-07. 0001493152-26-046202

    Accepted , ingested
  • Finley John David acquired 1,815,402 PALI shares on 2026-10-06, Form 4 filed 2026-10-07. 0001493152-26-046201

    Accepted , ingested